Latest Headlines

  1. Thermo Fisher Scientific To Invest $150M To Expand Pharma Services Capabilities

    Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it is investing $150 million in its Pharma Services business to provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing.

  2. Pall Corporation And ARTeSYN Biosolutions Collaboration Agreement Expanded To Accelerate Single-Use Technology Industrialization

    Pall Corporation, a global leader in filtration, separation and purification, announced the next step in the collaboration agreement with ARTeSYN Biosolutions, a leading innovator in single-use components and fluid management technologies.

  3. Particle Sciences Invests In Commercialization Expertise

    Particle Sciences, a Lubrizol LifeSciences company and pharmaceutical contract development and manufacturing organization (CDMO), has announced the appointment of Karen Bossert as vice president of operations as part of its ongoing strategy to grow and enhance its manufacturing capabilities.

  4. CDMO Ajinomoto Bio-Pharma Services Adds New Isolated Filling Line , Automated Packaging And Labeling Technologies

    Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading global provider of bio-pharmaceutical contract development and manufacturing provided an update on several of its capital projects currently underway in both the United States and Belgium.

  5. Meissner To Exhibit At BPI West 2019 In Santa Clara, CA, USA

    Meissner will be exhibiting at BioProcess International’s (BPI) West on March 11-14, 2019. The event will take place at the Santa Clara Convention Center, in Santa Clara, California, USA. Meissner will host visitors in booth #502.

  6. Pall Corporation And Broadley-James Cooperate To Deliver Next Generation Single-Use Sensor Technologies To The Life Science Market

    Pall Corporation, a global leader in filtration, separation and purification, has partnered with Broadley-James Corporation, a renowned sensor technology provider, to integrate and distribute Broadley-James’ advanced single-use probe and flow cell pH sensors.

  7. Meissner To Exhibit At ISPE’s Rocky Mountain Chapter Vendor Event

    Meissner will be exhibiting at the 24th Annual Rocky Mountain Chapter Vendor Event. The 2-day event will be held at the Westin, Westminister, Colorado. Opening day (Thursday) will run from 3:00 PM – 8:00 PM, and will include key note speakers and an exhibit hall highlighting new technologies.

  8. CDMO Goodwin Biotechnology To Double cGMP Biomanufacturing Capacity With Expansion

    Goodwin Biotechnology, Inc. announced that it has recently purchased the two-acre site where the company has flourished for over 26 years in order to expand its capacity to meet the needs of its long-term clients.

  9. Biogen To Purchase Gene Therapy Drug Manufacturer Nightstar Therapeutics For $800 Million

    Biogen Inc said on Monday it will buy Nightstar Therapeutics Plc for about $800M in cash as the company looks to tap into a potentially lucrative gene therapy market.

  10. Aldevron Announces Expansion Of Additional Laboratory And Production Space

    Aldevron announced recemtly from the floor of the Festival of Biologics in San Diego, its expansion plans for its Freiburg, Germany facility. The Freiburg location houses the GENOVAC antibody development platform and became the second site for Aldevron in 2004.